Frank Bringstrup
General Counsel bei CALLIDITAS THERAPEUTICS AB
Vermögen: 168 267 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Frank Bringstrup
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 28 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Frank Bringstrup
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Uppsala | College/University | Graduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| GENKYOTEX SA. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| SEDANA MEDICAL AB | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
| MEDCAP AB | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
| SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member Director/Board Member | |
Busulipo AB
 Busulipo AB Pharmaceuticals: MajorHealth Technology Busulipo AB is a Swedish company that manufactures and wholesales pharmaceutical and medical technology products. The private company is based in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| Stockholm School of Economics | College/University | Masters Business Admin Undergraduate Degree | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Treasurer Director/Board Member | |
| University of Lund | College/University | Graduate Degree Graduate Degree | |
| Georgia State University | College/University | Graduate Degree Masters Business Admin | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Pharmalink Nordic AB | Corporate Officer/Principal Director/Board Member | ||
Nefecon AB
 Nefecon AB Pharmaceuticals: MajorHealth Technology Part of Calliditas Therapeutics AB, Nefecon AB is a pharmaceutical company based in Stockholm, Sweden. The Swedish company has developed a patented oral, delayed release formulation of budesonide called nefecon, which is designed to target mucosal B-cells present in the ileum where the disease originates, as per the predominant pathogenesis models. Nefecon is derived from the targit technology, which allows for the substance to pass through the stomach and intestine without being absorbed, and to be released in a pulse-like fashion only when it reaches the lower small intestine. The company has completed a large phase 2b trial, which showed that the combination of dose and optimized release profile is required to be effective in patients with IgA nephropathy. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| BERGENBIO ASA | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Swevet Holding AB
 Swevet Holding AB Miscellaneous Commercial ServicesCommercial Services Swevet Holding AB is a supplier of medicines and consumables for animal care and veterinary operations. The private company is based in Sjobo, Sweden. The Swedish company has a wide range of products and offers fast delivery services. Swevet has extensive experience in the field, which enables it to provide safe advice on purchasing veterinary equipment and taking care of it. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| University of Oslo | College/University | Graduate Degree Doctorate Degree | |
| WEIFA ASA | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Director/Board Member | |
Copenhagen Capacity
 Copenhagen Capacity Financial ConglomeratesFinance Copenhagen Capacity provides investment promotion and economic development services. The private company is based in Copenhagen, Denmark. Asbjørn Overgaard Christiansen has been the CEO of the Danish company since 2020. | Financial Conglomerates | Director/Board Member | |
SpinChip Diagnostics AS
 SpinChip Diagnostics AS Electronic Equipment/InstrumentsElectronic Technology SpinChip Diagnostics AS develops a game changing and proprietary platform for in vitro diagnostics point of care analyses. Its point of care device will satisfy all key user requirements, both with respect to assaying performance and user-friendliness. The firm's platform combines swift analysis and ease of use with wide range of advanced analyses. The company was founded by Stig Morten Borch in February 2012 and is headquartered in Oslo, Norway. | Electronic Equipment/Instruments | Director/Board Member | |
Vitux Group AS
 Vitux Group AS Financial ConglomeratesFinance Vitux Group AS owns and operates other companies. The company was founded on September 15, 2006 and is headquartered in Oslo, Norway. | Financial Conglomerates | Director/Board Member | |
Numascale AS
 Numascale AS Computer Processing HardwareElectronic Technology Numascale AS provides a range of shared-memory server systems solutions and appliances. Its NumaConnect technology enables computer system vendors to build scalable system and allows high volume manufactured server boards to be used as building blocks for systems. The firm's product enables applications to scale beyond a single main board and includes support for virtualization of processing, memory, and input-output resources and can be used with standard operating systems. The company was founded by Einar Rustad and Kåre Løchsen in 2008 and is headquartered in Oslo, Norway. | Computer Processing Hardware | Director/Board Member | |
Curida AS
 Curida AS Pharmaceuticals: MajorHealth Technology Curida AS engages in the production of pharmaceutical products for other pharmaceutical companies, both in Norway and abroad. It manufactures and markets nasal and inhalation drug products. The company was founded in 1974 and is headquartered in Elverum, Norway. | Pharmaceuticals: Major | Director/Board Member | |
| Data-Consult AS | Corporate Officer/Principal | ||
St. Olavs Hospital hf
 St. Olavs Hospital hf Hospital/Nursing ManagementHealth Services St. Olavs Hospital HF provides general medical and surgical hospital services. The private company is based in Trondheim, Norway. The CEO of the Norwegian company is Grethe Aasved. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Orientekspressen AS | Corporate Officer/Principal | ||
| EXACT THERAPEUTICS | Biotechnology | Director/Board Member | |
Swedencare AB (publ)
 Swedencare AB (publ) Agricultural Commodities/MillingProcess Industries Swedencare AB (publ) offers a wide range of premium pet health products for dogs, cats, and horses. The private company is based in Malmö, Sweden. The Swedish company provides safe, natural, and easy-to-use dental care products such as Crunchy Dental Bites, Chews, Bones, Powder, and more. It was founded in 1993, and the CEO is Lars Håkan Lagerberg. | Agricultural Commodities/Milling | Director/Board Member | |
| Mabtech Group Holding AB | Chairman | ||
Shelterwood AS
 Shelterwood AS Financial ConglomeratesFinance Shelterwood AS invests in forestry related companies. The company was founded on August 16, 2018 and is headquartered in Oslo, Norway. | Financial Conglomerates | Director/Board Member | |
Mabtech Holding AB
 Mabtech Holding AB Financial ConglomeratesFinance Mabtech Holding AB provides financial support services. The private company is based in Nacka Strand, Sweden. | Financial Conglomerates | Chairman | |
| Immedica Pharma Holding AB | Director/Board Member | ||
| PROBI AB | Biotechnology | Director/Board Member | |
| ADDVISE GROUP AB | Medical Distributors | Director/Board Member | |
Bio-Works Sweden AB
 Bio-Works Sweden AB BiotechnologyHealth Technology Part of Bio-Works Technologies AB, Bio-Works Sweden AB is a Swedish company that specializes in the production of agarose-based chromatography resins for the purification of various biological substances such as monoclonal antibodies, proteins, peptides, oligos, viruses, and vaccines. The company is based in Uppsala, Sweden. The company's workbeads are known for their exceptional chromatography resins that can be used for laboratory research or large-scale bioprocess production. | Biotechnology | Director/Board Member | |
Genzyme Europe BV
 Genzyme Europe BV Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Europe BV is a Dutch company that develops and manufactures pharmaceutical and biotherapeutic products. The company is based in Amsterdam, Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Mabtech AB
 Mabtech AB Miscellaneous Commercial ServicesCommercial Services Mabtech AB manufactures immunological and biotechnological products. It produces a wide range of monoclonal antibodies to cytokines, immunoglobulins, and apolipoproteins for applications in life science research. The firm's products Elisa, Elispot, and Fluorospot Kits; antibodies; and supplementary products. The company was founded by Staffan Paulie, Kjell Olov Östrand, and Sten Braesch-Andersen in 1986 and is headquartered in Nacka Strand, Sweden. | Miscellaneous Commercial Services | Chairman | |
| Baxter Medical AB | Corporate Officer/Principal | ||
| BIO-WORKS TECHNOLOGIES AB | Biotechnology | Director/Board Member | |
J&J Future Invest AS
 J&J Future Invest AS Real Estate DevelopmentFinance J & J Future Invest AS is a Norwegian company that operates a real estate agency. | Real Estate Development | Corporate Officer/Principal | |
| PCI BIOTECH HOLDING ASA | Biotechnology | Director/Board Member | |
Blueprint Genetics Oy
 Blueprint Genetics Oy BiotechnologyHealth Technology Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland. | Biotechnology | Chairman | |
| COMBIGENE AB | Pharmaceuticals: Major | Director/Board Member | |
| Tappin AS | Director/Board Member |
Statistik
International
| Schweden | 26 |
| Norwegen | 18 |
| Vereinigte Staaten | 5 |
| Frankreich | 2 |
| Dänemark | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 6 |
| Finance | 6 |
| Commercial Services | 3 |
| Electronic Technology | 3 |
Operativ
| Director/Board Member | 162 |
| Corporate Officer/Principal | 66 |
| Chairman | 53 |
| Independent Dir/Board Member | 49 |
| Director of Finance/CFO | 24 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Thomas Lennart Eklund | 57 |
| Bengt Åke Julander | 36 |
| Elmar Schnee | 31 |
| Renée Aguiar-Lucander | 26 |
| Ann-Tove Kongsnes | 24 |
| Fred Driscoll | 21 |
| Hilde Furberg | 21 |
| Henrik Stenqvist | 16 |
| Diane Parks | 14 |
| Olav Hellebø | 13 |
| Margareta Elisabeth Björk | 12 |
| Johan Erik Häggblad | 11 |
| Åsa Hillsten | 11 |
| Molly Henderson | 10 |
| Fredrik Johansson | 10 |
- Börse
- Insiders
- Frank Bringstrup
- Unternehmensverbindungen
